Clinical Convergence®: Approaching Chronic Urticaria from the Patient Perspective

Activity Overview

Although chronic urticaria (CU) occurs in the population at low frequency, its impact on patients’ lives, including work productivity and social interactivity, is significant. The availability of evidence-based treatment guidelines has done little to curb the confusion surrounding appropriate diagnosis, treatment, and management of symptoms in patients with CU. Consequently, patients with CU continue to experience a lowered quality-of-life associated with the disease itself, as well as the side effects resulting from treatment.

0.75 CE Credit(s)
Expires: March 6, 2020

Target Audience

This activity is designed to meet the educational needs of S-based allergy/immunology and dermatology clinicians.

Learning Objectives

Upon successful completion of this education activity, participants should be better able to:

  • Recognize physical exam findings and symptomatology suggestive of chronic urticaria (CU) and appropriately apply evidence-based practices regarding diagnostic testing and laboratory workup
  • Utilize a guideline-driven approach to treatment intensification for safe and effective management of patients with CU in need of second- and third-line treatment options, while taking into account quality of life issues

Activity Faculty

Michael E. Manning, MD, FAAAAI, FACAAI

President/Medical Director
Medical Research of Arizona
Allergy, Asthma and Immunology Associates, Ltd.
Scottsdale, AZ

Anne Marie Ditto, MD

Associate Professor, Medicine
Division of Allergy-Immunology
Northwestern University
Feinberg School of Medicine
Chicago, IL